Clarity, structure, and momentum for leaders at critical inflection points.
CGI is a founder-led strategy consultancy that partners with scale-ups, investors, and boards during high-stakes transitions. When decisions stall, alignment fades, or investor expectations escalate — we help leadership teams rebuild clarity, embed structure, and regain control.
We work with innovation-driven companies navigating capital, regulation, and scale — particularly across compliance-heavy, investor-led, and globally complex markets.
“We help founders and boards turn insight into clarity, and clarity into motion. Whether you’re scaling, raising, or leading through change — we bring the structure, challenge, and momentum to move with confidence.”
Founder & CEO
CGI delivers high-trust, high-impact counsel where strategy, capital, and leadership converge.
We bring the rigour of a top-tier firm with the discretion, pace, and proximity of a founder-led model.
Frequently retained by GPs, chairs, and founders post-raise, during board evolution, or ahead of exits and market expansion.
Please Note: We do not provide regulated financial, investment, or tax advice. Strategic financial support (e.g., capital narrative, budgeting) is illustrative only and should be reviewed with qualified professionals.
We support leadership when clarity is urgent, and outcomes are high-stakes. Clients span regulated, innovation-led, and capital-intensive sectors across globally complex environments.
Leadership visibility, succession, and team design Regularly engaged to support founders post-raise, ahead of COO hires or delivery evolution.
Post-raise alignment, Series A–C readiness, and execution resets
Often brought in by GPs to support board evolution, delivery acceleration, or strategic repositioning.
Regulatory strategy, SAB design, and launch preparation
Helped a HealthTech CEO align SAB build, investor story, and FDA roadmap in parallel.
Strategic pivots, GTM narrative, and investor re-engagement Supported AI and B2B SaaS teams in pivot delivery, board refresh, and scale architecture.
Note: CGI accepts a limited number of biotech engagements per year, prioritising projects with strong scientific foundations and strategic clarity
Scientific platform design, market-entry, and capital narrative
Advised a rare disease biotech through SAB setup and Series B prep aligned to access milestones.
Leadership visibility, succession, and team design Regularly engaged to support founders post-raise, ahead of COO hires or delivery evolution.
Post-raise alignment, Series A–C readiness, and execution resets Often brought in by GPs to support board evolution, delivery acceleration, or strategic repositioning.
Regulatory strategy, SAB design, and launch preparation Helped a HealthTech CEO align SAB build, investor story, and FDA roadmap in parallel.
Strategic pivots, GTM narrative, and investor re-engagement Supported AI and B2B SaaS teams in pivot delivery, board refresh, and scale architecture.
Note: CGI accepts a limited number of biotech engagements per year, prioritising projects with strong scientific foundations and strategic clarity Scientific platform design, market-entry, and capital narrative Advised a rare disease biotech through SAB setup and Series B prep aligned to access milestones.
CGI was built to bridge the gap between traditional strategy firms and the intensity of real-world leadership.
How we think. How we operate. What we protect.
Our advisory network evolves with each mandate. Profiles below represent select strategic leads engaged on recent and ongoing projects.
Founder & CEO | Strategy & Leadership Advisor
A global board advisor and pharmacologist by training, Daniya works across capital, regulation, and organisational strategy. She’s advised teams in every major region, including through strategic engagements with several of the world’s top 10 pharmaceutical, biotech, heath tech and consumer health companies. She founded CGI to offer high-trust, high-impact counsel when stakes are high, and clarity is urgent.
Founder & CEO | Strategy & Leadership Advisor
A global board advisor and pharmacologist by training, Daniya works across capital, regulation, and organisational strategy. She’s advised teams in every major region, including through strategic engagements with several of the world’s top 10 pharmaceutical, biotech, heath tech and consumer health companies. She founded CGI to offer high-trust, high-impact counsel when stakes are high, and clarity is urgent.
Senior Advisor – Board Effectiveness & Governance
Over 15 years shaping succession, founder transition, and boardroom strategy across FTSE-listed companies, VC-backed scaleups, and mid-cap portfolios.
Senior Advisor – Medical & Regulatory Strategy
Physician and strategic advisor with experience in oncology, CNS, immunology, and rare disease. Supports biotech, MedTech, and pharma clients on regulatory readiness and medical affairs.
Senior Advisor – Strategic Finance & Investor Narrative
Advises growth-stage companies on financial narrative, investor strategy, and valuation clarity across Asia, Europe, and North America.
Advisor – Scientific Innovation & Translational Strategy
Supports biotech and MedTech teams on preclinical validation, SAB formation, and scientific-investor narrative. Based in Tokyo and Boston.
Advisor – Commercial Strategy & Emerging Markets GTM
Works with B2B and HealthTech scaleups on pricing and GTM architecture across Africa, MENA, and other complex jurisdictions.
Advisor – Strategic Operations & Delivery
Helps post-raise and founder-led companies build delivery rhythm, execution frameworks, and team operating models during growth or transformation.
Advisor – Capital & Growth Strategy
Advises digital health and SaaS ventures on investor alignment, capital modelling, and go-to-market strategy.
We take on a limited number of high-stakes engagements per quarter to ensure depth and senior attention.
If you’re at an inflection point, we’d be happy to explore fit.
Codex Group International — Clarity, structure and momentum for leaders at inflection points.
Stay updated with our latest insights and news.
© 2025 Codex Group International. All rights reserved.